LifeSci Venture Partners
Venture capitalNew York · Series A–Late Stage · 2 people tracked
Also known as LIFESCI VENTURE MANAGEMENT, LLC
Investment thesis
LifeSci Venture Partners focuses on the life sciences sector, backing biotech and pharmaceutical companies where its team brings clinical, scientific, and investment expertise. The firm emphasizes long-term conviction and hands-on partnership, playing an integral role in company formation and launch, guiding founders through investor storytelling, outreach, and closing strategies, and supporting portfolio companies over multiple ventures and across the investment lifecycle.
Source: firm website, verified Aug 3, 2026.
Team · 2 people
from the firm's website & public directories
What they invest in
from 5 of 6 portfolio companiesBiotech ×4Deep Tech ×2Digital Health ×1Enterprise Software ×1Healthtech ×1Medical Devices ×1New Materials ×1
HQs:United States×4
Investments · 6 tracked
founders shown can be your intro pathErasca is a clinical-stage oncology company developing therapies targeting RAS- and MAPK pathway-driven cancers using a modality-agnostic approach including small molecules, large molecules, and protein degraders.
BiotechDeep TechDigital HealthMedical DevicesSan Diego, US
Pratik S. Multani, M.D.(Director)Valerie Harding-Start(Director)Jonathan E. Lim, M.D.(President and Executive Chairman)Gary Yeung, CFA(Chief Business Officer)Alexander W. Casdin(Director)James A. Bristol, Ph.D.(Director)
BiotechTel Aviv
Shmuel Cabilly(Director)June Almenoff(Executive Officer)Ofer Tsimchi(Director)Rick D Scruggs(Executive Officer, Director)Nicolas Weinstein(Director)Alla Felder(Director)
PartnerPaul Yook· solo GP
Windsor, US
Chris Camarsh(Director)James P. Linton(Executive Officer, Director)Marc-Francois Pelletier(Executive Officer, Director)Paul Predki(Executive Officer, Director)Stephanie Ann George(Executive Officer)
Board seatPaul Yook· per SEC Form D · $6M raise · filed Nov 2021
Company whose formation and launch the LifeSci team supported.
BiotechHealthtechSummit, US
Jouko Isojarvi(Executive Officer)Stephen D. Collins(Director)Gregory Mayes(Executive Officer, Director, Promoter)Gerry Brunk(Director)Heath Lukatch(Director)Warren Lammert(Director)
PartnerPaul Yook· solo GP
BiotechPittsburgh, US
Raymond K. Houck(President, Chief Executive Officer and Director of Issuer)Lalit Chordia(Director)Mazen Hanna(Chief Scientific Officer)Ira Kalfus(Chief Medical Officer of Issuer)Philip Sussman(Director)Robert Roy(Director)
PartnerPaul Yook· solo GP
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does LifeSci Venture Partners invest at?
- LifeSci Venture Partners invests at the Series A, Series B, Series C, Late Stage stages.
- What sectors does LifeSci Venture Partners focus on?
- LifeSci Venture Partners focuses on Biotech, Healthtech, Medical Devices.
- Where is LifeSci Venture Partners located?
- LifeSci Venture Partners is headquartered in New York, US.
- Does LifeSci Venture Partners lead rounds?
- LifeSci Venture Partners typically participates in rounds rather than leading them.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.